Introduction China has an estimated 5 million people with tuberculosis (TB). Official policy is that treatment of all patients is directly observed by health workers; completion rates are reported to be in excess of 90%, and drugs should be supplied for free. However, some research suggests there is a gap between the official policies and practice.
Methods
Survey of TB patients in four counties of one municipality; record assessment at one TB centre; patient and village doctor in-depth interviews.
Results
Sixteen per cent (64/401) reported being directly observed every time they took treatment; less than 5% of TB patients (17/401) were observed by health staff. Overall, 12.5% (50/401) reported they had not taken any TB drugs in the previous week, but this varied between the four counties (range 6.2 to 21.7%).
We used survival analysis with medical records at one centre: 74.1% of new patients collected their drugs for their sixth month of treatment, and 50.3% attended the final visit at 6 months. Qualitative research indicated direct observation is neither well understood nor thought to be necessary, and that patients reported being charged expensive fees for ancillary treatments, such as liver protection drugs.
Conclusion In China, direct observation is not well implemented and may not be a feasible policy option. Official completion rates are higher than we found in this study. The concept of free treatment has become blurred, with charges for additional tests and drugs, especially liver protection drugs. The government is already actively tackling these issues, and involvement of managers and others in this process will be helpful. (World Health Organization 2004) , and were being observed by health workers when taking their treatments. Performance data collected through the public health system report cure rates of more than 90% (Chen et al. 2002; Wang et al. 2007) . These widely varying figures give cause for concern. In addition, there appear to be problems with implementing the policy of free or subsidized treatment that is part of the China National TB Programme (World Bank 1991) .
Given the debates around effective policy implementation, this research was carried out at the instigation of a Municipal TB programme in collaboration with researchers, to identify ways that TB health service delivery could be improved. The research aimed to: a) measure the level of direct observation by health workers; b) estimate the completion rate from data within facilities; and c) explore patient and provider views on factors influencing adherence.
Methods

Study sites
The study municipality is Chongqing, in South West China, with a population of 30 million, living in a mountainous area, with a socio-economic profile below average. The Health Bureau and the municipal TB dispensary implement the TB control programme. In each of the 40 counties, the programme is implemented by the county TB dispensary or the County Centre for Disease Control. In our study, we purposively selected four counties as representative of the whole of Chongqing, in terms of socio-economic development, geographic and transportation condition. This is illustrative of an urban area (JLP), a middle socio-economic area (RC and LB) and a poor rural area (XS) (see Table 1 ). All sites had TB information systems, appropriate health staff, and were willing to cooperate. Official statistics put completion rates at about 90% for new patients, in line with the national average. However, as this was inconsistent with other resources (National Technical Steering Group of the Epidemiological Sampling Survey for TB 2004), we therefore assessed adherence by a patient survey, and made an independent estimate from individual patient records at one County TB Dispensary where records were reasonably well kept and performance was likely to be optimal.
Patient survey
Smear-positive TB patients who started treatment within the preceding year (that is, currently on treatment or completed treatment recently) were the target population of this study. A sample size of 369 was calculated based on a required precision of AE5% around the 95% confidence interval of adherence rate. The estimated adherence rate used in sample size calculation is 60%, according to a pilot estimation using medical records information. As there were approximately 800 patients meeting the criteria across the four counties, we sampled every other smear-positive TB patient registered in the preceding year at each of the county TB dispensaries.
Patients were asked 'how often did anybody observe you taking anti-TB drugs?' and four choices were given: 'every time, most times (more than half), rare (less than half), and none'. The government national guidelines explicitly state that patients should be observed 'every time' (Centre for Disease Control 2002). Since TB patients were taking medicine every other day, 'Interruption of treatment' was defined as those who missed their last three doses; or had run out of medicine for more than a week. 'Interruption of treatment' among patients recently completing treatment was defined as those who stopped taking drugs 6 days before the end of the standard
KEY MESSAGES
Direct observation of drug taking by a health worker is national policy for TB control in China. In the study area described, less than 5% of patients were directly observed, and health workers and patients did not consider the policy feasible or necessary.
Records showed that less than 50% of new patients attended follow up at six months, and irregular treatment and failure to complete treatment was common under the direct observation policy. This will contribute to the risk of drug-resistant TB developing and to relapse.
Anti-TB treatment is supposed to be free, but patients were charged high costs for additional tests and drugs, especially liver protection drugs. This may represent a considerable financial barrier for TB patients to adhere to treatment. Despite optimistic estimates from international agencies, current policies, their implementation, and actual TB cure and completion rates in various areas of China need to be reviewed. course, or who had run out of medicine for more than a week before the end of the standard course. This method provides a measure, at one point in time, of a patient's self-reported recent drug-taking history.
We trained and carefully supervised four postgraduate students to interview patients. Patients on treatment or recently completed were identified at each TB dispensary from the registration book. Most interviews with TB patients were conducted in their homes; for those patients living far away, notice was sent out and they were interviewed at the nearest township health centre. Community health workers and local health staff were not present during the interview. When a patient could not be found, we tried to identify and interview another patient in the village meeting the same criteria. Each evening, research supervisors checked the completed questionnaires and interviewed the interviewers to make sure all the items in the questionnaire were correctly understood and filled in. The data were double entered by two postgraduate students using Epi Data 2.1. After validation, the data were analysed using SAS 8.2. Two key indicators (direct observation and interruption of treatment) were defined and analysed. Univariate analysis was applied to find out the influencing factors.
Records analysis at JLP
Monthly summaries of attendance and completion were recognized as being inaccurate. Therefore, we went to the original patient records and monitored completion over an 8 month period (January to August of 2004) at the county TB dispensary, which included both patients who had completed their treatment and those currently on treatment. We collected medical records of both new and re-treatment patients. New patients were defined as patients who had never had treatment for TB, or who had taken anti-TB drugs for less than 1 month. Re-treatment patients were those previously treated for TB whose treatment failed, who defaulted, or who relapsed. The collection and recording of these data was supervised by the principal investigator.
We applied survival analysis (Kaplan-Meier method) to estimate the completion rate. In the analysis, 'event' was defined as patients who withdrew from the standardized short course chemotherapy because of death, treatment failure, default or transferring out. 'Survival time' was the time interval from the start of treatment to the 'event' of withdrawal. The unit of 'survival time' was by month, as patients were expected to attend clinics monthly. Patients attending the clinic on the fifth month, where they would collect their drugs for their last month of treatment, were considered as 'treatment completed'. We also calculated the percentage attending for the final visit at 6 months when cure would normally be assessed.
In-depth interviews
We interviewed TB patients (33) and village doctors (11) from all four counties. In each county, we purposefully selected patients from the county TB register to capture a range of experiences and views, considering age, gender and including both new and re-treatment patients.
All participants who were asked to participate agreed to be interviewed. Village doctors (eight male, three female) were recruited and interviewed. Standard topic guides were used to ensure relevant areas were covered during interviews, including patient and doctor's opinions about: DOT implementation, adherence to treatment, cost of TB treatment and patient management. Interviews were conducted in Chinese Mandarin, lasted between 30-50 minutes and were taperecorded with participants' informed consent. Interviews were conducted in participant's homes or at the nearest township health centre.
The Framework approach was applied to analyse qualitative data from in-depth interviews (Richie and Lewis 2003) , and MAXqda software was employed to manage, code and retrieve data. Tape recordings were transcribed verbatim in Chinese characters. Two bilingual (Mandarin/English speaking) team members read through the transcriptions and listed recurring viewpoints relevant to the areas of questioning and common themes emerging from the data; this formed the basis of the thematic framework. Transcriptions were imported into MAXqda (in Chinese characters) and a coding system set up based on the thematic framework. Code labels were in English as MAXqda does not support Chinese labelling. One author applied the coding system to all interviews.
A bilingual and a non-Mandarin speaking researcher examined the frequency of coded segments, and combined codes into larger categories, to form six main themes. Coded segments relevant to each theme were translated into English and summarized in a chart. This enabled English and bilingual researchers to look across the data of all cases and explore differences between sub-groups (patients and doctors, male and female, new and re-treatment patients, and across counties). The dimensions of each main theme and differences between subgroups are described in the results section; illustrative verbatim quotes for each theme appear in Boxes 1 to 6 in the Appendix in both Chinese mandarin and English. Of the patients interviewed, 19 were men, 14 were women of a wide variety of ages; 23 were new patients; 10 were re-treatment patients; 8 lived in the city, 11 in a rural hilly area, 6 in a rural mountainous area, and 8 in a very remote area.
Ethics and funding
Ethical approval was obtained from Chongqing Medical University. The study was funded by the Ministry of Health and the Department for International Development UK. The funding bodies had no involvement with the study design, analysis or interpretation of the results.
Results
Patient survey
Four hundred and five patients were interviewed (four excluded because of starting treatment more than 1 year ago). One-third of new patients were treated for longer than the standard treatment of 6 months. One-fifth of re-treatment patients (19/90) were treated for longer than the standard of 8 months (Table A1 in Appendix). In younger age groups, there were similar numbers of men and women, but men predominated in the older groups (Table A2) . Only 16% (64/401) of patients reported that they were directly observed every time they took their drugs (95% CI: 12.4% to 19.6%); 72% reported that they had never been observed (Table 2) . Less than 5% (17/401) were directly observed by a health worker, and 15 of these patients were from one particular county where authorities had actively encouraged village doctors to contribute to TB control (RC county). The remaining 11% were observed by family members. Analysis by gender, age group and basic knowledge about TB showed no association.
At the time of interview, 12.5% (95% CI: 9.2% to 15.7%) of patients reported 'interrupted treatment' by our definition (missed last three doses, or run out of medicines for more than a week). This varied considerably by county from 6.2% at JLP to over 20% in XS (Table 3) .
Interruption of treatment was similar in patients who reported being directly observed and those who did not report being observed. Interruption was more common in men, and in people who stated they believed that TB drugs could be stopped after TB symptoms disappeared (Table 3) . Table 4 gives the results from the Kaplan Meier analysis from study site JLP. Of the 151 patients, 1 died (after 1 month), 2 transferred out (missed 2 month appointment), and 2 were identified as treatment failure (at 3 and 4 months). In this group, the most optimistic completion estimate is those attending the clinic 5 months into the treatment, when, for new patients, their last 1 month of drugs is dispensed. For new patients, this was 74.1% with 50.3% attending at 6 months, when a sputum check was normal practice. There were fewer patients classed as re-treatment, where standard treatment is meant to be 8 months of treatment: 64.5% attended the 5 month visit, and 42.9% attended at 6 months. 
Completion
Qualitative findings
Six main themes arose through the analysis using the Framework approach. They represent factors that may influence DOT implementation and adherence.
1) Most TB patients are responsible themselves for taking their drugs Most TB patients said that they took drugs on their own at home and knew nothing about the records of drug taking (see Box 1 in Appendix). Some reported that they lived very close to the village doctor but did not have any supervision of drug taking. Some even felt surprised when hearing the term 'direct observation'. None of the village doctors interviewed mentioned that they directly observed each dose taken by TB patients. Most of them said that they provided intermittent home visits and/or telephone calls to remind patients of taking drugs. Some also acknowledged that they never manage TB patients in the way of DOT. Village doctors in XS County said that they had neither heard about it before nor were they required to conduct it (Box 1).
2) Patients and village doctors regard direct observation as unnecessary
Many patients reported it was unnecessary to be directly observed by a doctor. They felt they were able to remember to take the medicine by themselves; some said they were motivated to take their drugs because they wanted to be cured and recover. A few patients regarded supervision as a 'bother' to the doctors and a waste of their time. During interviews, most village doctors said that, with constraints of limited time, long distance and lack of incentives, it was unrealistic and unnecessary for them to conduct DOT (Box 2).
3) Most new patients comply with treatment
The majority of new patients interviewed said that they never forgot to take drugs during the treatment (see Box 3). Village doctors believed that most TB patients could keep taking drugs, because they wanted to be cured as early as possible. However, a minority of doctors gave us examples of patients who had stopped treatment for various reasons, such as drug side-effects and financial difficulty.
4) Most patients report they are charged expensive fees for treatment
Most patients said that they had to pay for TB treatment. Among them, only a few could differentiate free (anti-TB drugs) and charged drugs (liver protection drugs) (see Box 4) . Patients complained that it cost them tens to hundreds of Yuan to buy 'additional' drugs and examinations relating to their treatment; many reported having to borrow money to afford treatment. The cost of treatment varied between the counties; patients in RC county described a higher cost for drugs, on average 200-300 Yuan per month (£13-£20 per month). The high cost of treatment was also one of the main reasons mentioned by patients who interrupted drug taking. Village doctors reported that patients complained to them about the high cost of treatment, and that they cannot afford examinations and additional drugs.
5) Stigma exists in communities
Many patients described being treated differently by people in their immediate communities after getting TB. They suggested neighbours or friends did not like to talk with them, or kept a certain distance while talking with them for fear of infection (see Box 5) . TB patients tended to conceal their disease from others for fear of being isolated. Some described being treated differently by family members. Village doctors also reported that community residents did not like to get close to TB patients, because they were afraid of being infected.
6) Village doctors report incentives are less important than responsibility Village doctors are supposed to receive 60 Yuan (£4) through the World Bank/DFID-assisted TB programme for managing one TB patient for 6 months, but the level of financial support and implementation of incentive payments varies by county; one village doctor from RC county said he had never heard about the incentive payment. Most village doctors interviewed suggested that even without this money, it was their responsibility to manage TB patients (see Box 6). Some village doctors also expressed that fixed financial support would help them to manage patients effectively, since they currently do not receive any salary from the government, and have to earn their own living through fees for service.
Discussion
The study results show that health worker direct observation of TB treatment was low. At county level, between 6.2 to 21.7% of patients had run out of drugs, or not taken any in the previous week; and actual completion rates in one county studied were lower than reported in national statistics. We paid careful attention to quality. In the questionnaire, we minimized respondent bias by using carefully trained independent interviewers; in the medical record data for survival analysis, the principal investigator monitored data collection; and for the qualitative interviews, we paid careful attention to content and analysis by applying the Framework approach rigorously to the Chinese narrative. The main constraint of this study relates to the extent to which it reflects adherence in other areas of China, as it was carried out in a limited number of counties. However, there is no reason to believe the study site has any worse performance than other provinces in China, and there is a need for more extensive careful recording of true adherence. In the patient survey, our replacement strategy would tend to make adherence seem better than it actually was; nevertheless, it was still low.
The national guideline is that all smear-positive TB patients should be directly observed for treatment by community health providers or family members. WHO reported high levels of direct observation (World Health Organization 2004) and others have reported good completion rates (Chen et al. 2002; Wang et al. 2007) . Our study showed only 16% of TB patients were directly observed when taking anti-TB drugs. Whilst the China reporting system does not actually record whether patients are directly observed during treatment, nevertheless the stated national policy is for direct observation.
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We decided to be cautious in our interpretation of the question about direct observation by family members. The reason for this is that we were not clear whether respondents simply meant that family members happened to be in the room when they were taking treatment. The concept of direct observation by another person, including family members, was really quite unfamiliar, and we did not check whether 'observation' actually also included active participation of the family member in the whole process. If they are to take on more of a monitoring role, it is likely that training and instructions will be required. Health staff did not view the policy as practical or feasible.
Most village doctors are now private practitioners, have no government salary and make a living through fees for services. Implementing direct observation is a time-consuming job. Though the World Bank/DFID-assisted TB control programme provides 60 Yuan to a village doctor for managing one TB patient, this money is not always available; if it were available, 60 Yuan is simply not enough payment for the inputs that are required. This is probably the explanation for some village doctors reporting that incentives were less important than responsibility.
The official completion rate in the county we studied was 91.6%, yet our analysis of records, which was in part prospective, indicated the most optimistic completion rate proxy for new cases was 74.1% (percentage of new patients starting treatment who visit on month 5 for their last month's treatment), with only 50.3% attending the final visit at 6 months. These completion data are from the best performing centre (JLP) among the four centres, since JLP is one urban district of Chongqing city and its TB control programme is managed by a provincial-level facility, while the other three are all in rural areas and managed by county-level TB dispensaries. Performance at other centres is likely to be worse, and certainly self-reported adherence rates at the other centres were much lower. Thus it is probable that true adherence is considerably lower at the other centres, and these patients are important as they are at risk of relapse.
Whether these management issues we identified around routine statistics are common in other counties in the country was not the brief of our study, but certainly the findings indicate some very careful audit and checking is required before being confident about the apparent high level of performance of the national TB programme. We would argue that there is a need for accurate information at all levels in order for staff to take remedial action: in the county, to follow up individual patients; in the province, to identify poorly performing counties; nationally, to help poorly performing provinces; and overall, to identify areas that are doing well to explore reasons for best practice.
In addition, the survey of reported patient adherence suggested irregular treatment was common, with patients frequently missing doses. This will contribute to the risk of drug-resistant TB developing.
The interviews with patients and health staff indicated that far from being free, patients were charged high costs for the diagnosis and treatment. This appears to be for additional tests and drugs, especially liver protection drugs, which are widely recommended by the doctors and appear to be a way of generating income from patients. These findings are consistent with other research around charging (Garner and Ziganshina 2005; Xu et al. 2006) , and suggest that there may be considerable financial barriers to starting and continuing treatment.
These problems are mainly rooted within the malfunctioning health system. Along with the market-oriented economic reform, government funds for public health facilities are limited. Now these services rely heavily on service charges, encouraging public health facilities to supply revenue-generating services. This is probably why patients always receive liver protection drugs and prolonged treatment (Meng et al. 2004 ). In such circumstances, village doctors, most of whom receive no salary from government, have no incentive to take responsibility for DOT.
With the collapse of the programme of rural health insurance (Feng et al. 1997) , it costs the rural poor a lot of money for health care, even if the health services are supposed to be 'free ' (Meng et al. 2004 ). This will contribute extensively to TB patients' interruptions and non-adherence to treatment.
The next step is to verify whether the situation found in these selected counties is similar elsewhere in the country. Strategic options include both specific approaches to detect and promptly respond to defaulters (Garner and Ziganshina 2005), or to involve families (Newell et al. 2006) . If family members are to play the role of direct observation, they need more appropriate training and supervision. However, the gains with these approaches are likely to be minimal as there is a broader, underlying problem. To tackle the systems issues, key measures need to be taken to improve the whole health system performance. It could benefit from further investment from government subsidy to assist health facilities and health staff at county, township and village levels in delivering treatments that have significant externalities. Improving and expanding the pilot rural health insurance schemes will also provide more financial protection to the poor rural population in seeking appropriate TB health services. 
